• It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Cassava Sciences: "They do have an Alzheimer's trial, but Lilly has an Alzheimer's formulation that is very good. And Lilly does have the edge on everybody else."

WATCH ANYTIME FOR FREE

>Stream NBC10 Boston news for free, 24/7, wherever you are.

Mobileye Global: "...I think it's just too hard to tell, I'm going to stay away from it."

Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Money Report

news 9 mins ago

This cruise line is offering an unlimited pass for $120,000 — and you can pay in bitcoin: Here's what to know

news 14 mins ago

3 ways to lower stress this holiday season: ‘Sometimes less celebration means more joy,' happiness expert says

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Also on CNBC

• Jim Cramer explains why investors should wait out 'sloppy' post-earnings trading
• Cramer says reports from Wells Fargo and JPMorgan are 'good omens' for earnings season
• Cramer's Lightning Round: Uranium Energy is 'the real deal'

Subscribe to the CNBC YouTube Channel

Morning Squawk Newsletter